NCT00360126View on ClinicalTrials.gov

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

lamotrigine

Trial Locations (3)

2065

GSK Investigational Site, Greenwich

4005

GSK Investigational Site, New Farm

4053

GSK Investigational Site, Everton Park

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY